Early regulatory operations planning key to submission-ready dossiers
Regulatory operations are often treated as a final step after all scientific data are compiled, but the article argues they should be integrated from the start of a development program.
A dossier that contains all required content is not automatically ready for filing; it must also meet strict technical, compliance and navigational standards to allow regulators to assess the evidence efficiently.
Publishing a New Drug Application or Marketing Authorization Application requires specialized knowledge of eCTD architecture, validation criteria, metadata handling and document lifecycle management, far beyond basic publishing software.
Experienced regulatory publishers bring foresight, identifying potential issues early and ensuring the submission progresses in parallel with the overall regulatory strategy, which can streamline review and reduce delays.
This writeup was produced by pharmadog from original reporting by BioPharma Dive.
Original headline: “Regulatory operations: The overlooked half of submission readiness”
read at BioPharma Dive ↗
comments(0)
5-min edit window · permanent after that